| Literature DB >> 31076358 |
Congqing Wu1, Wei Lu2, Yan Zhang1, Guoying Zhang1, Xuyan Shi3, Yohei Hisada4, Steven P Grover4, Xinyi Zhang2, Lan Li2, Binggang Xiang1, Jumei Shi5, Xiang-An Li6, Alan Daugherty7, Susan S Smyth8, Daniel Kirchhofer9, Toshihiko Shiroishi10, Feng Shao3, Nigel Mackman4, Yinan Wei11, Zhenyu Li12.
Abstract
Inflammasome activation and subsequent pyroptosis are critical defense mechanisms against microbes. However, overactivation of inflammasome leads to death of the host. Although recent studies have uncovered the mechanism of pyroptosis following inflammasome activation, how pyroptotic cell death drives pathogenesis, eventually leading to death of the host, is unknown. Here, we identified inflammasome activation as a trigger for blood clotting through pyroptosis. We have shown that canonical inflammasome activation by the conserved type III secretion system (T3SS) rod proteins from Gram-negative bacteria or noncanonical inflammasome activation by lipopolysaccharide (LPS) induced systemic blood clotting and massive thrombosis in tissues. Following inflammasome activation, pyroptotic macrophages released tissue factor (TF), an essential initiator of coagulation cascades. Genetic or pharmacological inhibition of TF abolishes inflammasome-mediated blood clotting and protects against death. Our data reveal that blood clotting is the major cause of host death following inflammasome activation and demonstrate that inflammasome bridges inflammation with thrombosis.Entities:
Keywords: DIC; GSDMD; LPS; caspase; coagulation; inflammasome; macrophage; pyroptosis; sepsis; tissue factor
Mesh:
Substances:
Year: 2019 PMID: 31076358 PMCID: PMC6791531 DOI: 10.1016/j.immuni.2019.04.003
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745